Mechanochemical synthesis and in vitro anti-Helicobacter pylori and uresase inhibitory activities of novel zinc(II)–famotidine complex

References

• Kubiak M, Duda AM, Ganadu ML, Kozlowski H. Crystal structure of a copper(II)-famotidine complex and solution studies of the Cu2+-famotidine-histidine ternary system. J Chem Soc Dalton Trans 1996:1905–8.
   Google Scholar
• Baranska M, Lasocha W, Kozlowski H, Proniewicz LM. New solid state Ni(II)-famotidine square-planar complex: powder diffraction and spectroscopic studies. J Inorg Biochem 2004;98:995–1001.
   Web of Science ®Google Scholar
• Djenana UM, Bogdanovic GA, Miodragovic ZM, Radulovic MD, Novakovic SB, Kaluderovic GNH, et al. Interesting coordination abilities of antiulcer drug famotidine and antimicrobial activity of drug and its cobalt(III) complex. J Inorg Biochem 2006;100:1568–74.
   PubMed Web of Science ®Google Scholar
• Merck Index, 13th ed. O’Neil MJ, Smith A, Heckelman PE. Whitehouse Station, NJ: Merck & Co., 2001.
   Google Scholar
• Martindale: The Complete Drug Reference, 35th ed. Seetman SC. London: Pharmaceutical Press, 2006.
   Google Scholar
• Andrews M, Gallagher-Allred C. The role of zinc in wound healing. Adv Wound Care 1999;12:137–8.
   PubMedGoogle Scholar
• Ito M, Inaguma K, Suzuki Y, Segami T, Suzuki Y. Healing-promoting action of the zinc-cimetidine complex on acetic acid-induced gastric ulcers in Rats. Jpn J Pharmacol 1995;68:287–295.
   PubMedGoogle Scholar
• Conchillo A, Mola C, Navarro C, Bravo L, Bulbena Q. Cytoprotective and antisecretory activity of a ranitidine-zinc complex. Prost Leuko Essen Fatty Acids 1995;52:393–7.
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonisation. Q3C: Impurities: guideline for residual solvents, Step 4, July 1997. Geneva: ICH, 1997.
   Google Scholar
• Gary AL, Pichon A, James SL. Solvent-free synthesis of metal complexes. Chem Soc Rev 2007;84:636.
   Google Scholar
• Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720–41.
   PubMed Web of Science ®Google Scholar
• Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, et al. Short-term low dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol 1994;6:773–7.
   Web of Science ®Google Scholar
• Cruickshank R, Duguid JP, Marmion BP, Swain RHA. Medical Microbiology, 12th ed. Edinburgh: McGraw-Hill, 1975:109–12.
   Google Scholar
• Megraud F, Lehn N, Lind T, Bayerdorffer E, O’Morain C, Spiller R, et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 1999;43:2747–52.
   PubMed Web of Science ®Google Scholar
• Wu H, Shi D, Wang HT, Liu JX. Resistance of Helicobacter pylori to metronidazole, tetracycline and amoxicillin. J Antimicrob Chemother 2000;46:121–3.
   PubMed Web of Science ®Google Scholar
• Serwar M, Akhtar T, Hameed S, Khan KM. Synthesis, urease inhibition and antimicrobial activities of some chiral 5-aryl-4-(1-phenylpropyl)-2H-1,2,4-triazole-3(4H)-thiones. ARKIVOC 2009;(vii):210–21.
   Google Scholar
• Akhter T, Hameed S, Khan KM, Choudhry MI. Synthesis, urease inhibition, and antimicrobial studies of some chiral 3-substituted-4-amino-5-thioxo-1H,4H-1,2,4-triazole. Med Chem 2008;4:539–43.
   PubMed Web of Science ®Google Scholar
• Perveen S, Khan KM, Lodhi MA, Choudhary MI, Atta-ur-Rahman, Voelter W. Urease and α-chymotrypsin inhibitory effects of selected urea derivatives. Lett Drug Des Discov 2008;5:401–5.
   Web of Science ®Google Scholar
• Zaheer-ul-Haq, Lodhi MA, Nawaz SA, Iqbal S, Khan KM, Rode BM, et al. 3D-QSAR CoMFA sudies on bis-coumarine analogues as urease inhibitors: a strategic design in anti-urease agents. Bioorg Med Chem 2008;16:3456–61.
   PubMed Web of Science ®Google Scholar
• Pervez H, Iqbal MS, Tahir MY, Nasim FU, Choudhary MI, Khan KM. In vitro cytotoxic, antibacterial, antifungal and urease inhibitory activities of some N4-substituted isatin-3-thiosemicarbazones. J Enzyme Inhib Med Chem 2008;23:848–54.
   PubMed Web of Science ®Google Scholar
• Amtul Z, Follmer C, Mahboob S,Atta-ur-Rahman, Mazhar M, Khan KM, et al. Germa-γ-lactones as novel inhibitors of bacterial urease activity. Biochem Biophys Res Commun 2007;356:457–63.
   PubMed Web of Science ®Google Scholar
• Jamal RA, Ashiq U, Tahir MM, Maqsood ZT, Khan KM, Lodhi MA, et al. Chemistry, urease inhibition, and phytotoxic studies of binuclear vanadium (IV) complexes. Chem Biodiver 2007;4:58–71.
   PubMed Web of Science ®Google Scholar
• Khan KM, Zia-Ullah, Lodhi MA, Ali M, Choudhary MI, Atta-ur-Rahman, et al. Successful computer guided planned synthesis of (4R)-thiazolidine carboxylic acid and its 2-substituted analogues as urease inhibitors. Mol Divers 2006;10:223–31.
   PubMed Web of Science ®Google Scholar
• Amtul Z, Kausar N, Follmer C, Rozmahel RF, Atta-ur-Rahman, Kazmi SA, et al. Cytseine based novel noncompetitive inhibitors of urease(s)-distinctive inhibition susceptibility of microbial and plant ureases. Bioorg Med Chem 2006;14:6737–44.
   PubMed Web of Science ®Google Scholar
• Khan KM, Zafar SS, Lodhi MA, Butt N, Perveen S, Maharvi GM, et al. Piperidines: a new class of urease inhibitors. Nat Prod Res 2006;20:523–30.
   PubMed Web of Science ®Google Scholar
• Khan KM, Iqbal S, Lodhi MA, Maharvi GM, Perveen S, Choudhary MI, et al. Synthesis and urease enzyme inhibitory effects of some dicoumarols. J Enzyme Inhib Med Chem 2004;19:367–72.
   PubMed Web of Science ®Google Scholar
• Khan KM, Iqbal S, Lodhi MA, Maharvi GM, Zia-Ullah, Choudhary MI, et al. Biscoumarine: new class of urease inhibitors; economical synthesis and activity. Bioorg Med Chem 2004;12:1963–8.
   PubMed Web of Science ®Google Scholar
• Amtul Z, Rasheed M, Choudhary MI, Rosanna S, Khan KM, Atta-ur-Rahman. Kinetics of novel competitive inhibitors of urease enzymes by a focused library of oxadiazoles/thiadiazoles and triazoles. Biochem Biophys Res Commun 2004;319:1053–63.
   PubMed Web of Science ®Google Scholar
• Weatherburn MW. Phenol-hypochlorite reaction for determination of ammonia. Anal Chem 1967;39:971–4.
   Web of Science ®Google Scholar
• Nagata K, Mizuta T, Tonokatu Y, Fukuda Y, Okamura H, Hayashi T, et al. Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations. Infect Immunol 1992;60:4826–31.
   PubMed Web of Science ®Google Scholar
• Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493–7.
   Google Scholar
• www.sciencelab.com
   Google Scholar
• Walsh CT, Sandstead HH, Prasad AS, Newberne PM Fraker PJ. Zinc: health effects and research priorities for the 1990s. Environ Health Perspect 1994;102:5–46.
   PubMed Web of Science ®Google Scholar
• Rainsford KD, Goldie J, Hunt RH. Zinc compounds combined with cyclodextrin inhibit growth of Helicobacter pylori in-vitro. Pharm Sci 1997;3:483–5.
   Google Scholar
• Mobley HLT, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol Rev 1995;59:451–80.
   PubMedGoogle Scholar